Le Lézard
Classified in: Health
Subject: MRR

Hemodialysis and Peritoneal Dialysis Market Worth $126.2 billion | MarketsandMarketstm

CHICAGO, April 18, 2024 /PRNewswire/ -- Hemodialysis and Peritoneal Dialysis Market in terms of revenue was estimated to be worth $92.0 billion in 2024 and is poised to reach $126.2 billion by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarketstm.

MarketsandMarkets Logo

Globally, the growing burden of chronic diseases like diabetes, hypertension, the rising incidence of ESRD globally are anticipated to accelerate the demand for renal care, further propelling the adoption of hemodialysis and peritoneal dialysis products and services. Moreover, the rising advancements in dialysis machines, development of biocompatible dialysis membranes, dialysis fluid, and portable & home based dialysis equipment are likely to fuel the market growth. Moreover, the increasing investments for new product development and growing adoption of home dialysis modality owing to its advantages over in center dialysis treatment modality are expected to support the hemodialysis and peritoneal dialysis market growth during the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279

Browse in-depth TOC on "Hemodialysis and Peritoneal Dialysis Market"
150 - Tables
65 - Figures
350 - Pages

Hemodialysis and Peritoneal Dialysis Market Scope:

Report Coverage


Market Revenue in 2024

$92.0 billion

Estimated Value by 2029

$126.2 billion

Growth Rate

Poised to grow at a CAGR of 6.5%

Market Size Available for


Forecast Period


Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Product and Services, Disease Indication, End user, and Region

Geographies Covered

North America (US & Canada), Europe (Germany, the UK, France, Italy, Spain, and RoE), APAC (Japan, China, Australia, South Korea India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA (GCC Countries, RoMEA)

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

High growth potential of emerging markets

Key Market Drivers

Rising prevalence of chronic kidney disease globally

Vascular complication associated with dialysis procedures and lack of well established reimbursement and coverage for dialysis in many economic countries, reducing the affordability of dialysis treatment among patients with kidney diseases are likely to hamper the growth of hemodialysis and peritoneal dialysis market.

The hemodialysis services segment, by hemodialysis products and services, is expected to register the largest market share of the global hemodialysis market in 2023.

The hemodialysis market is segmented based on product and service. Hemodialysis products include hemodialysis machines and hemodialysis consumables & supplies, whereas hemodialysis services include in-center services and home services. The hemodialysis services segment is anticipated to grow at significant rate during the forecast period. This is attributed to the increasing utilization of in-center and home hemodialysis services among ESRD patients and the rising number of hemodialysis services providers with strong focus on expanding their hemodialysis services. In March 20254, DaVita Inc., a hemodialysis service provider announced the expansion of its international operation across Latin America.

"The APAC market, by region, to register highest growth rate in the forecast period."

On the basis of region, the hemodialysis and peritoneal dialysis market is segmented into North America, Europe, Asia Pacific, and the Latin America, Middle East & Africa.  The Asia-Pacific market is likely to witness significant market growth. This is attributed to the rise in geriatric patient population, increasing cases of chronic kidney diseases, moreover, improving healthcare infrastructure and the implementation of supportive government initiatives to increase the accessibility of dialysis services in many APAC countries such as India and China. The geographical expansion of key players, and emergence of many local players in the region are likely to support  growth of the hemodialysis  and peritoneal dialysis  market in Asia Pacific.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279

Hemodialysis and Peritoneal Dialysis Market Dynamics:


  1. Rising prevalence of chronic kidney disease globally


  1. Complications linked with dialysis procedures


  1. High growth potential of emerging markets


  1. Product Recall

Key Market Players of Hemodialysis and Peritoneal Dialysis Industry:

As of 2023, prominent players in the patient monitoring market are Medtronic (Ireland), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), GE Healthcare (US), Abbott Laboratories (US) and Boston Scientific Corporation (US), among others.

A breakdown of the primary participants referred to for this report is provided below:

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1279

Hemodialysis and Peritoneal Dialysis Market - Key Benefits of Buying the Report:

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Related Reports:

In Vitro Diagnostics Market - Global Forecasts to 2029

Endoscopy Equipment Market - Global Forecasts to 2029

Urology Devices Market - Global Forecasts to 2028

Top 10 Medical Device Technologies Market - Global Forecasts to 2027

Medical Supplies Market - Global Forecasts to 2027

About MarketsandMarketstm:

MarketsandMarketstm has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarketstm is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStoretm (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarketstm.com or follow us on Twitter, LinkedIn and Facebook.

Mr. Aashish Mehra
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/dialysis-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/dialysis.asp

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg


These press releases may also interest you

at 16:30
Sienna Senior Living Inc. ("Sienna" or the "Company") is pleased to announce that it has received shareholder approval in respect of all resolutions to be voted upon at its annual and special meeting of shareholders held on May 29, 2024 (the...

at 16:15
Bruker Corporation ("Bruker" or the "Company") today announced the launch of an underwritten registered public offering of 6,000,000 shares of its common stock. In addition, Bruker expects to grant the underwriters a 30-day option to purchase up to...

at 16:15
CareRx Corporation ("CareRx" or the "Company") , Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that as part of the Company's commitment to Board refreshment and to realign...

at 16:15
Jazz Pharmaceuticals plc today announced that Company management will participate in the following investor conferences: Jefferies Global Healthcare Conference on Thursday, June 6, 2024 Fireside chat at 11:00 a.m. PT / 2:00 p.m. ET / 7:00 p.m....

at 16:10
Nuvation Bio Inc. , a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, announced today that David Hung, M.D., Founder,...

at 16:10
Vir Biotechnology, Inc. today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, at 11:00...

News published on and distributed by: